Artificial Intelligence (AI) continues to permeate every sector, including the pharmaceutical industry, and plays a critical role in drug discovery and development. In particular, AI aids in determining the safety and toxicityRead More…
The advent of artificial intelligence (AI) and genomics, two highly promising scientific fields, has brought about ground-breaking advancements in the health and medical sectors. Their integration has transformed how we approach drugRead More…
AI drug development is a cutting-edge field that combines innovative drugs with AI. With the rising popularity of ChatGPT, AI drug development has once again garnered widespread attention. The application of AIRead More…
In recent years, the use of artificial intelligence (AI) and machine learning (ML) has become increasingly prevalent in drug development and therapeutic areas. The U.S. Food and Drug Administration (FDA) defines AIRead More…
Antibody drugs have emerged as a crucial therapeutic strategy for treating various diseases, including cancer, infectious diseases, and autoimmune diseases. As drug companies and research institutions fervently develop these drugs, artificial intelligenceRead More…
Therapeutic antibodies are one of the most successful classes of biotherapeutics available, but the traditional antibody development process is cumbersome and has significant limitations. Using artificial intelligence (AI) to speed up theRead More…
With more clinical candidates and commercial success than ever within this rapidly developing space, multi-specifics is evidently the fourth wave of drug discovery. It’s a great honor for Creative Biolabs to participateRead More…